The guidance offers definitions, information on what should be submitted in a Custom Device Annual Report and other recommendations on submitting the annual report.
The FDA is accepting comments on the draft guidance for the next 60 days.
To view the draft guidance in full, please click here.
More Articles on the FDA:
FDA Approves First Gel Sealant for Leaking Cornea After Cataract Surgery
FDA Recalls Covidien’s Puritan Bennett 840 Ventilator
FDA, Google X Researchers Meet, Spur Rumors of New Device
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
